Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ROIV | ASND | ITCI | ||
Company | Roivant Sciences Ltd | Ascendis Pharma ADR | Intra-Cellular Ther | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 10.48 | 134.46 | 69.00 | ||
High | 10.67 | 136.30 | 69.72 | ||
Low | 10.33 | 132.38 | 68.16 | ||
Last | 10.65 | 135.81 | 69.56 | ||
Change | +0.17 | +1.63 | +0.49 | ||
% Change | +1.62% | +1.21% | +0.71% | ||
Volume | 4,281,700 | 107,200 | 467,100 | ||
20-Day Average Volume | 5,367,135 | 270,930 | 1,765,075 | ||
Previous Close | 10.48 | 134.18 | 69.07 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 10.68 | 131.65 | 70.49 | ||
20-Day Raw Stochastic | 51.95% | 80.33% | 26.89% | ||
20-Day Relative Strength | 47.65% | 52.87% | 49.93% | ||
Weighted Alpha | -0.79 | +46.72 | +13.53 | ||
Today's Opinion | 24% Sell | 16% Buy | 72% Buy | ||
Previous Opinion | 40% Sell | Hold | 40% Buy | ||
Last Month's Opinion | 40% Buy | 8% Buy | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.76% since 06/27/24 | +0.30% since 06/27/24 | -2.00% since 06/27/24 | ||
Low | 10.33 on 07/05/24 | 132.27 on 07/01/24 | 66.26 on 07/01/24 | ||
High | 10.89 on 07/01/24 | 138.11 on 07/01/24 | 71.86 on 07/01/24 | ||
1-Month | |||||
%Chg | -2.11% since 06/05/24 | -1.94% since 06/05/24 | +2.58% since 06/05/24 | ||
Low | 10.25 on 06/10/24 | 121.07 on 06/20/24 | 66.26 on 07/01/24 | ||
High | 11.02 on 06/25/24 | 139.42 on 06/06/24 | 78.53 on 06/18/24 | ||
3-Month | |||||
%Chg | -9.28% since 04/05/24 | -9.39% since 04/05/24 | +1.64% since 04/05/24 | ||
Low | 10.19 on 05/31/24 | 116.63 on 05/14/24 | 64.09 on 05/20/24 | ||
High | 11.80 on 04/08/24 | 156.84 on 04/10/24 | 84.89 on 04/16/24 | ||
6-Month | |||||
%Chg | -5.50% since 01/05/24 | +4.69% since 01/05/24 | +1.55% since 01/05/24 | ||
Low | 9.69 on 02/05/24 | 116.63 on 05/14/24 | 62.78 on 02/22/24 | ||
High | 12.00 on 03/04/24 | 161.00 on 02/26/24 | 84.89 on 04/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 7,867,389 | 7,908,351 | 7,343,796 | ||
Shares Outstanding, K | 738,722 | 58,231 | 105,575 | ||
Annual Sales | 124,800,000 | 288,670,000 | 464,370,000 | ||
Annual Net Income | 4,348,930,000 | -521,070,000 | -139,670,000 | ||
Last Quarter Sales | 28,930,000 | 104,110,000 | 144,870,000 | ||
Last Quarter Net Income | -151,120,000 | -142,260,000 | -15,250,000 | ||
60-Month Beta | 1.24 | 0.63 | 1.01 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.23 on 05/30/24 | -2.48 on 05/02/24 | -0.16 on 05/07/24 | ||
Latest Earnings Date | 08/12/24 | 05/02/24 | 08/01/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |